Literature DB >> 24178837

Free-GABA levels in the cerebrospinal fluid of patients suffering from several neurological diseases Its potential use for the diagnosis of diseases which course with inflammation and tissular necrosis.

A T Zepeda1, F J Ortiz Nesme, J Méndez-Franco, E Otero-Siliceo, M Pérez de la Mora.   

Abstract

Free GABA levels were measured in the cerebrospinal fluid (CSF) of 74 neurological patients suffering from cerebral cysticercosis (n = 9), Parkinson's disease (n = 5), multiple sclerosis (n = 6), epilepsy (n = 24), meningeal tuberculosis (n = 6), viral encephalitis (n = 3), cerebrovascular disease (n = 8) and several kinds of dystonia (n = 5). A statistical significant four-fold elevation in free GABA levels was found in patients with cerebral cysticercosis. A non statistical significant two-fold increase in free GABA levels was also encountered in the CSF of patients affected by cerebrovascular disease and viral encephalitis. No changes in CSF free GABA levels were found in patients suffering from any of the other disorders. It is suggested that free GABA levels may be elevated in the CSF of patients suffering from neurological diseases which course with inflammation and tissular necrosis such as cerebral cysticercosis. Much work is needed however to establishd whether CSF free GABA levels can be used as a diagnostic tool in at least some type of these patients.

Entities:  

Year:  1995        PMID: 24178837     DOI: 10.1007/BF00805952

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  27 in total

1.  A simple, sensitive and specific radioreceptor assay for endogenous GABA in brain tissue.

Authors:  S J Enna; S H Snyder
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

2.  GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.

Authors:  P M Crawford; D W Chadwick
Journal:  Epilepsy Res       Date:  1987 Nov-Dec       Impact factor: 3.045

3.  Stability of GABA levels in CSF under various conditions of storage.

Authors:  M H Grossman; T A Hare; N V Manyam; B S Glaeser; J H Wood
Journal:  Brain Res       Date:  1980-01-20       Impact factor: 3.252

4.  The relationship of antibody levels to the clinical spectrum of human neurocysticercosis.

Authors:  D Zini; V J Farrell; A A Wadee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

5.  Mebendazole.

Authors:  J S Keystone; J K Murdoch
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

6.  Automated assay of gamma-aminobutyric acid in human cerebrospinal fluid.

Authors:  P Böhlen; P J Schechter; W van Damme; G Coquillat; J C Dosch; J Koch-Weser
Journal:  Clin Chem       Date:  1978-02       Impact factor: 8.327

7.  Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.

Authors:  B V Manyam; R D Tremblay
Journal:  Brain Res       Date:  1984-07-30       Impact factor: 3.252

8.  Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.

Authors:  N V Manyam; L Katz; T A Hare; J C Gerber; M H Grossman
Journal:  Arch Neurol       Date:  1980-06

9.  Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.

Authors:  S J Enna; L Z Stern; G J Wastek; H I Yamamura
Journal:  Arch Neurol       Date:  1977-11

10.  Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.

Authors:  H Perschak; U Amsler; A Vischer; J Siegfried; M Cuénod
Journal:  Hum Neurobiol       Date:  1987
View more
  2 in total

Review 1.  Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.

Authors:  Georgia Mandolesi; Antonietta Gentile; Alessandra Musella; Diego Fresegna; Francesca De Vito; Silvia Bullitta; Helena Sepman; Girolama A Marfia; Diego Centonze
Journal:  Nat Rev Neurol       Date:  2015-11-20       Impact factor: 42.937

Review 2.  Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF Markers.

Authors:  Roni Manyevitch; Matthew Protas; Sean Scarpiello; Marisa Deliso; Brittany Bass; Anthony Nanajian; Matthew Chang; Stefani M Thompson; Neil Khoury; Rachel Gonnella; Margit Trotz; D Blaine Moore; Emily Harms; George Perry; Lucy Clunes; Angelica Ortiz; Jan O Friedrich; Ian V J Murray
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.